m<sup>6</sup>A RNA modification and myeloid-derived suppressor cells: mechanistic insights and clinical prospects. [PDF]
Li C +7 more
europepmc +1 more source
Rewriting the RNA code: an m<sup>6</sup>a-centric framework to classify tumors and guide combination therapies. [PDF]
Sun Y +6 more
europepmc +1 more source
The methyltransferase METTL16 in digestive system cancers: functions and mechanisms. [PDF]
Li J, Bao Y, Yao F, Wu Q.
europepmc +1 more source
RBM15B recognizes H3K79me2 to guide selective m<sup>6</sup>A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia. [PDF]
Chen TQ +13 more
europepmc +1 more source
Epitranscriptomic regulation via m6A RNA methylation: a determinant of cancer immunotherapy response. [PDF]
Batool ST, Ali U, Mahato RK.
europepmc +1 more source
The Regulatory Role of m6A Modification in the Function and Signaling Pathways of Animal Stem Cells. [PDF]
Yang X +5 more
europepmc +1 more source
RMzyme: regulations of RNA-modifying enzymes in humans. [PDF]
Luo R +14 more
europepmc +1 more source
Raw signal segmentation for estimating RNA modification from Nanopore direct RNA sequencing data. [PDF]
Cheng G, Vehtari A, Cheng L.
europepmc +1 more source
M6AREG 2.0: the landscape of m6A-centered crosstalk with diverse epigenetic regulation. [PDF]
Yang M +11 more
europepmc +1 more source
FUS is an N1- and N6-methyladenosine-binding protein. [PDF]
Liang X +13 more
europepmc +1 more source

